DiaMedica Therapeutics - Stock Price History | DMAC

Historical daily share price chart and data for DiaMedica Therapeutics since 2021 adjusted for splits. The latest closing stock price for DiaMedica Therapeutics as of October 22, 2021 is 4.02.
  • The all-time high DiaMedica Therapeutics stock closing price was 10.43 on February 19, 2021.
  • The DiaMedica Therapeutics 52-week high stock price is 10.88, which is 170.6% above the current share price.
  • The DiaMedica Therapeutics 52-week low stock price is 3.00, which is 25.4% below the current share price.
  • The average DiaMedica Therapeutics stock price for the last 52 weeks is 6.65.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
DiaMedica Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.8462 4.8600 10.1400 2.2500 10.1400 109.07%
2019 3.3498 3.2300 5.0400 1.8000 4.8500 66.67%
2018 3.1433 3.4900 3.6200 2.6500 2.9100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.076B $0.001B
DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76